# Acclinate

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/acclinate

- Industry: Information Services
- Headquarters: Birmingham, US
- Website: www.acclinate.com
- Total disclosed funding: $6M
- Latest round: Series A (May 3, 2024)
- Investors on record: 3

## About

Based in Alabama, US, and founded in 2020 by co-founders Del Smith and Tiffany Whitlow, Acclinate, Inc. is a provider of a platform that allows organizations to make existing trials inclusive and locate and plan more diverse studies. The company's platform improves health equality by utilizing a special blend of ongoing community involvement and predictive analytics. In May 2024, Acclinate, Inc. raised USD 7 million in Series A funding led by investor Cencora Ventures, with participation from other investors Labcorp and Latimer Ventures.

The company’s product offering is a three-step engagement process: it analyzes data to identify underrepresented communities and develops targeted strategies for outreach and education. Acclinate's NOWINCLUDED platform serves as a central hub for educational resources and community engagement. It provides culturally relevant information about clinical trials, their importance in medical advancements, and the potential benefits for participants. The company connects interested individuals with relevant clinical trial opportunities and ongoing communication to maintain engagement and address any questions or concerns.

The company plans to use May 2024 funding to expand its influence in the areas of clinical trial diversity and health equality.

## Funding rounds

- Series A, May 3, 2024, $6M — LabCorp Ventures, Latimer Ventures, Cencora Ventures

## Investors

- LabCorp Ventures (https://capitalatlas.ai/funds/labcorp-ventures) — Series A
- Latimer Ventures (https://capitalatlas.ai/funds/latimer-ventures) — Series A
- Cencora Ventures (https://capitalatlas.ai/funds/cencora-ventures) — Series A